BioAtla LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

BioAtla LLC (BioAtla) is a biotechnology company that develops novel monoclonal antibodies and other cell based therapeutics. The company utilizes proprietary conditionally active biologics and comprehensive integrated antibody optimization platforms to develop novel therapies. It develops drugs for various cancer indications such as NSCLC, breast, pancreatic, ovarian, aml, liver, esophageal and prostate. BioAtla partners with other organizations to advance a CAB immune checkpoint inhibitor and the selected CAB-ADCs into commercial products. The company offers laboratories in the US and China. BioAtla is headquartered in San Diego, California, the US.

BioAtla LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
BioAtla LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioAtla LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioAtla LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioAtla LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioAtla LLC, Medical Devices Deals, 2012 to YTD 2018 9
BioAtla LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioAtla LLC, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
BioAtla Raises USD3 Million in Venture Financing 11
Partnerships 12
BioAtla Expands its Agreement with Beijing Sinobioway 12
BioAtla Enters into Co-Development Agreement with BioDuro 13
BioAtla And EpiVax Partner For Antibody Screening Technology 14
Licensing Agreements 15
F1 Oncology Enters into Licensing Agreement with BioAtla 15
Pfizer Enters into Licensing Agreement with BioAtla 16
BioAtla Enters Into Licensing Agreement With BioMotiv 17
ADC Therapeutics Enters Into Licensing Agreement With VivaMab For VM101 18
Equity Offering 19
BioAtla to Raise USD45 Million in Financing 19
BioAtla Raises USD30 Million in Private Placement of Shares 20
BioAtla LLC - Key Competitors 21
BioAtla LLC - Key Employees 22
BioAtla LLC - Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Corporate Communications 24
Sep 10, 2018: BioAtla names Scott Smith as President 24
Jul 24, 2018: BioAtla names Lawrence Fong as scientific advisor 25
May 09, 2017: BioAtla Appoints Yong Ben, M.D., As Chief Medical Officer 26
Clinical Trials 27
Jan 24, 2018: BioAtla Announces FDA Clearance of IND Application for CAB-AXL-ADC Therapeutic 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List Of Tables


BioAtla LLC, Pharmaceuticals & Healthcare, Key Facts 2
BioAtla LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioAtla LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioAtla LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioAtla LLC, Deals By Therapy Area, 2012 to YTD 2018 8
BioAtla LLC, Medical Devices Deals, 2012 to YTD 2018 9
BioAtla LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioAtla Raises USD3 Million in Venture Financing 11
BioAtla Expands its Agreement with Beijing Sinobioway 12
BioAtla Enters into Co-Development Agreement with BioDuro 13
BioAtla And EpiVax Partner For Antibody Screening Technology 14
F1 Oncology Enters into Licensing Agreement with BioAtla 15
Pfizer Enters into Licensing Agreement with BioAtla 16
BioAtla Enters Into Licensing Agreement With BioMotiv 17
ADC Therapeutics Enters Into Licensing Agreement With VivaMab For VM101 18
BioAtla to Raise USD45 Million in Financing 19
BioAtla Raises USD30 Million in Private Placement of Shares 20
BioAtla LLC, Key Competitors 21
BioAtla LLC, Key Employees 22
BioAtla LLC, Subsidiaries 23

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

BioAtla LLC - Pharmaceuticals and Healthcare - Deals and Alliances Profile

BioAtla LLC (BioAtla) is a biotechnology company that develops novel monoclonal antibodies and other cell based therapeutics. The company utilizes proprietary conditionally active biologics and comprehensive integrated antibody optimization platforms

USD 250 View Report

BioAtla LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

BioAtla LLC (BioAtla) is a biotechnology company that develops novel monoclonal antibodies and other cell based therapeutics. The company utilizes proprietary conditionally active biologics and comprehensive integrated antibody optimization platforms

USD 250 View Report

IXYS LLC - Strategic SWOT Analysis Review

IXYS LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on

USD 125 View Report

Prometheon Pharma LLC - Product Pipeline Analysis, 2019 Update

Prometheon Pharma LLC - Product Pipeline Analysis, 2019 Update market research report available in single user pdf license with Aarkstore Enterprise at USD 750

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available